Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 5Sarcoma 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Non-Hodgkin 17Dendritic Cell Sarcoma, Interdigitating 17Multiple Myeloma 16Lymphoma, Mantle-Cell 16Lymphoma, Large-Cell, Immunoblastic 16Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Follicular 16Lymphoma, B-Cell, Marginal Zone 16Leukemia, Myeloid, Acute 16Leukemia, Lymphocytic, Chronic, B-Cell 16Hodgkin Disease 16Burkitt Lymphoma 16Recurrence 14Myelodysplastic Syndromes 14Myeloproliferative Disorders 13Congenital Abnormalities 13Neoplasms, Plasma Cell 12Lymphoma 12Leukemia, Myeloid, Accelerated Phase 12Leukemia 12Primary Myelofibrosis 10Leukemia, Myeloid, Chronic-Phase 10Blast Crisis 10Sezary Syndrome 9Mycosis Fungoides 9Lymphoma, T-Cell, Cutaneous 9Leukemia, Myelomonocytic, Juvenile 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Waldenstrom Macroglobulinemia 8

Interventions

Cyclophosphamide 23Temozolomide 14Filgrastim 13Irinotecan 12Melphalan 11Etoposide 10Carboplatin 9Vincristine 8Peripheral Blood Stem Cell Transplantation 8Granulocyte Colony-Stimulating Factor 8X-Rays 7Topotecan 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Busulfan 7fludarabine 6Thiotepa 6Phantoms, Imaging 6fludarabine phosphate 5Radiotherapy 5Biopsy 5Antilymphocyte Serum 5Oxaliplatin 4Nuclear Medicine Department, Hospital 4Nivolumab 4Methylprednisolone 4Ifosfamide 4Cisplatin 4palbociclib 3olaparib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neuroblastoma × Tacrolimus × Sarcoma × Clear all
NCT01804634 2026-03-13

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
60 enrolled
CNSGastrointestinalSarcoma

Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡